Literature DB >> 22593164

Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Takasuke Fukuhara1, Hiroto Kambara, Mai Shiokawa, Chikako Ono, Hiroshi Katoh, Eiji Morita, Daisuke Okuzaki, Yoshihiko Maehara, Kazuhiko Koike, Yoshiharu Matsuura.   

Abstract

Hepatitis C virus (HCV) is one of the most common etiologic agents of chronic liver diseases, including liver cirrhosis and hepatocellular carcinoma. In addition, HCV infection is often associated with extrahepatic manifestations (EHM), including mixed cryoglobulinemia and non-Hodgkin's lymphoma. However, the mechanisms of cell tropism of HCV and HCV-induced EHM remain elusive, because in vitro propagation of HCV has been limited in the combination of cell culture-adapted HCV (HCVcc) and several hepatic cell lines. Recently, a liver-specific microRNA called miR-122 was shown to facilitate the efficient propagation of HCVcc in several hepatic cell lines. In this study, we evaluated the importance of miR-122 on the replication of HCV in nonhepatic cells. Among the nonhepatic cell lines expressing functional HCV entry receptors, Hec1B cells derived from human uterus exhibited a low level of replication of the HCV genome upon infection with HCVcc. Exogenous expression of miR-122 in several cells facilitates efficient viral replication but not production of infectious particles, probably due to the lack of hepatocytic lipid metabolism. Furthermore, expression of mutant miR-122 carrying a substitution in a seed domain was required for efficient replication of mutant HCVcc carrying complementary substitutions in miR-122-binding sites, suggesting that specific interaction between miR-122 and HCV RNA is essential for the enhancement of viral replication. In conclusion, although miR-122 facilitates efficient viral replication in nonhepatic cells, factors other than miR-122, which are most likely specific to hepatocytes, are required for HCV assembly.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22593164      PMCID: PMC3421686          DOI: 10.1128/JVI.00567-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

Review 1.  Natural history of chronic hepatitis C.

Authors:  Leonard B Seeff
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

2.  Specific detection of minus-strand hepatitis C virus RNA by reverse-transcription polymerase chain reaction on PolyA(+)-purified RNA.

Authors:  S T Takyar; D s Li; Y h Wang; R Trowbridge; E J Gowans
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

3.  Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.

Authors:  Thomas Pietschmann; Volker Lohmann; Artur Kaul; Nicole Krieger; Gabriele Rinck; Gabriel Rutter; Dennis Strand; Ralf Bartenschlager
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

5.  Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex.

Authors:  Denise Egger; Benno Wölk; Rainer Gosert; Leonardo Bianchi; Hubert E Blum; Darius Moradpour; Kurt Bienz
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection.

Authors:  Robert E Lanford; Elisabeth S Hildebrandt-Eriksen; Andreas Petri; Robert Persson; Morten Lindow; Martin E Munk; Sakari Kauppinen; Henrik Ørum
Journal:  Science       Date:  2009-12-03       Impact factor: 47.728

7.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

Review 8.  Extrahepatic manifestations of chronic HCV infection.

Authors:  Alessandra Galossi; Riccardo Guarisco; Lia Bellis; Claudio Puoti
Journal:  J Gastrointestin Liver Dis       Date:  2007-03       Impact factor: 2.008

9.  Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Authors:  Keril J Blight; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

10.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Authors:  Matthew J Evans; Thomas von Hahn; Donna M Tscherne; Andrew J Syder; Maryline Panis; Benno Wölk; Theodora Hatziioannou; Jane A McKeating; Paul D Bieniasz; Charles M Rice
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

View more
  47 in total

1.  The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection.

Authors:  Jian Tao; Kyung-Don Kang; Stacy D Hall; Audra H Laube; Jia Liu; Matthew B Renfrow; Jan Novak; Guangxiang Luo
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

2.  A conserved RNA structural element within the hepatitis B virus post-transcriptional regulatory element enhance nuclear export of intronless transcripts and repress the splicing mechanism.

Authors:  Akasit Visootsat; Sunchai Payungporn; Nattanan P T-Thienprasert
Journal:  Mol Biol Rep       Date:  2015-10-29       Impact factor: 2.316

Review 3.  Virus meets host microRNA: the destroyer, the booster, the hijacker.

Authors:  Yang Eric Guo; Joan A Steitz
Journal:  Mol Cell Biol       Date:  2014-07-21       Impact factor: 4.272

4.  Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.

Authors:  Emilie Estrabaud; Martine Lapalus; Philippe Broët; Kevin Appourchaux; Simon De Muynck; Olivier Lada; Michelle Martinot-Peignoux; Ivan Bièche; Dominique Valla; Pierre Bedossa; Patrick Marcellin; Michel Vidaud; Tarik Asselah
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

5.  Hepatitis C virus (HCV) interaction with astrocytes: nonproductive infection and induction of IL-18.

Authors:  Ziqing Liu; Fang Zhao; Johnny J He
Journal:  J Neurovirol       Date:  2014-03-27       Impact factor: 2.643

Review 6.  Hepatitis C virus infection, microRNA and liver disease progression.

Authors:  Shubham Shrivastava; Anupam Mukherjee; Ratna B Ray
Journal:  World J Hepatol       Date:  2013-09-27

7.  Human Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle Formation.

Authors:  Francesc Puig-Basagoiti; Takasuke Fukuhara; Tomokazu Tamura; Chikako Ono; Kentaro Uemura; Yukako Kawachi; Satomi Yamamoto; Hiroyuki Mori; Takeshi Kurihara; Toru Okamoto; Hideki Aizaki; Yoshiharu Matsuura
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

8.  Increasing expression of microRNA 181 inhibits porcine reproductive and respiratory syndrome virus replication and has implications for controlling virus infection.

Authors:  Xue-kun Guo; Qiong Zhang; Li Gao; Ning Li; Xin-xin Chen; Wen-hai Feng
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  Heterogeneous Ribonucleoprotein K (hnRNP K) Binds miR-122, a Mature Liver-Specific MicroRNA Required for Hepatitis C Virus Replication.

Authors:  Baochang Fan; F X Reymond Sutandy; Guan-Da Syu; Stefani Middleton; Guanghui Yi; Kuan-Yi Lu; Chien-Sheng Chen; C Cheng Kao
Journal:  Mol Cell Proteomics       Date:  2015-09-01       Impact factor: 5.911

Review 10.  Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?

Authors:  Ivan Rusyn; Stanley M Lemon
Journal:  Cancer Lett       Date:  2013-07-18       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.